Kamada Ltd

KMDA

Company Profile

  • Business description

    Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, the Proprietary Products segment and the Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.

  • Contact

    2 Holzman Street
    P.O. Box 4081
    Science Park
    Rehovot7670402
    ISR

    T: +972 89406472

    E: [email protected]

    https://www.kamada.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - Specialty & Generic

    Fiscal Year End

    31 December 2026

    Employees

    374

Stocks News & Analysis

stocks

Goldman Sachs Earnings: Valuations remain stretched

We raise our fair value estimate for Goldman Sachs stock.
stocks

Major ASX listed miners overvalued

We’ve adjusted our fair values after updating our commodity price assumptions.
stocks

Undervalued ASX share with pathway to positive cash flow

Higher sales and a new loan facility increase our conviction.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,195.0012.30-0.13%
CAC 408,258.9454.18-0.65%
DAX 4025,297.1355.26-0.22%
Dow JONES (US)49,359.3383.11-0.17%
FTSE 10010,235.293.65-0.04%
HKSE26,844.9678.66-0.29%
NASDAQ23,515.3914.63-0.06%
Nikkei 22553,255.15681.02-1.26%
NZX 50 Index13,640.5377.57-0.57%
S&P 5006,940.014.46-0.06%
S&P/ASX 2008,875.308.40-0.09%
SSE Composite Index4,101.910.00-0.00%

Market Movers